Serving in the CEO role since 2016, Dr. Miller leads Johns Hopkins Hospital, a 1,100-bed academic medical center with over 11,000 employees and $3.6 billion in operating revenue. Her leadership has enhanced clinical care, quality, safety, patient experience and health equity at the hospital, as recognized by year-after-year “honor roll” listings from U.S. News & World Report. It was the first academic medical center to achieve Planetree International gold certification for person-centered care. The hospital’s advancements include increasing the number of heart transplants from 25 just two years ago to over 70 in 2025, with 90-day and conditional one-year survival over 90%. Along with extracorporeal membrane oxygenation growth and Impella device placements, it is one of the nation’s busiest cardiac transplant programs. A $150 million investment in cell and gene therapy will boast advanced infrastructure, a lab and innovative therapies to better treat human diseases. Xenotransplantation breakthroughs include continuing focus on the bench research underpinning the field, as well as participation in National Institutes of Health’s first clinical trial to transplant genetically modified animal organs into patients with organ failure. The decade-old, first-in-the-U.S. Capacity Command Center is the model others work to emulate, improving efficiency of patient throughput and clinical care throughout the Johns Hopkins Health System, prioritizing quality, safety and the institution’s tripartite mission of innovative research, education and patient care. A practicing internist, Dr. Miller combines clinical experience with leadership to ensure high-quality patient care and staff support. She is also an associate professor in the department of medicine, with honors including induction into the National Academy of Medicine and the Maryland Chamber of Commerce Business Hall of Fame.
